The BioFINDER studies are independent and non-overlapping studies that have been initiated with the overarching aims to discover key mechanisms in Alzheimer’s disease, Parkinson’s disease and other neurodegenerative disorders. These studies are designed to develop early and accurate diagnostic tests, identify novel treatment targets and help to understand the links between different pathologies and clinical symptoms.
In the article “The History of Alzheimer’s Disease”, the editors of Nature journals share their insights on this topic....
Read more...A commercially available blood test has now been trialled in routine healthcare. “The blood test showed about 90% reliability...
Read more...Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care
Revised criteria for the diagnosis and staging of Alzheimer’s disease
Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathology
Tau Positron Emission Tomography for Predicting Dementia in Individuals With Mild Cognitive Impairment